InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (7 ops.)
Insider track record
CEODisclosed buys
3
Disclosed sells
7
T+90 hit rate
0%
T+90 mean return
-21.3%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Eltoukhy Helmy, Chairman & CEO. Insider active across 1 company, notably Guardant Health, Inc.. In total, 19 reports have been published. Breakdown: 3 buys · 7 sells. Total volume traded: €19.4m. History available since 13 August 2021. The latest transaction was disclosed on 5 June 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations19 total
33,843 shares@ US$126.32630.019% mcap18.1% of flowCommon StockSEC:0001752968-26-000010:1
1,100 shares@ US$127.02410.0006% mcap0.6% of flowCommon StockSEC:0001752968-26-000010:2
13,787 shares@ US$128.25110.0080% mcap7.5% of flowCommon StockSEC:0001752968-26-000010:3
554 shares@ US$130.20540.0003% mcap0.3% of flowCommon StockSEC:0001752968-26-000010:4
900 shares@ US$131.78440.0005% mcap0.5% of flowCommon StockSEC:0001752968-26-000010:5
100 shares@ US$132.550.0001% mcap0.1% of flowCommon StockSEC:0001752968-26-000010:6
49,716 shares@ US$125.5690.028% mcap26.4% of flowCommon StockSEC:0001752968-26-000010:0
4,814 shares0Common StockSEC:0001576280-25-000104:0
68,769 shares0Common StockSEC:0001576280-25-000084:0
11,462 shares0Common StockSEC:0001576280-25-000004:0
11,461 shares0Common StockSEC:0001576280-24-000226:0
11,462 shares0Common StockSEC:0001576280-24-000158:0
200,000 shares@ US$4.188.2% of flowCommon StockSEC:0001576280-24-000100:0
11,461 shares0Common StockSEC:0001576280-24-000072:0
84,452 shares@ US$26.333421.8% of flowCOMMON STOCKSEC:0001576280-23-000040:0
Ideal exit: 9 Dec 2023 (T+270)
37,591 shares@ US$97.90420.026% mcap48.7% of flowCOMMON STOCKSEC:0001576280-21-000109:0
Ideal exit: 16 Aug 2022 (T+270)
37,591 shares@ US$97.904234.1% of flowCOMMON STOCKSEC:0001576280-21-000109
Ideal exit: 16 Aug 2022 (T+270)
23,923 shares@ US$4.180.9% of flowCOMMON STOCKSEC:0001576280-21-000086
23,923 shares@ US$4.180.0007% mcap1.3% of flowCOMMON STOCKSEC:0001576280-21-000086:0
19 of 19 declarations
About Eltoukhy Helmy
Helmy Eltoukhy is the Co-Chief Executive Officer of Guardant Health, Inc. He leads the company in developing diagnostic solutions for cancer. Helmy is committed to transforming healthcare through technological innovations and patient-centered approaches.
